marketnetra
Sign inStart free

Aurobindo Pharma Limited

NSE: AUROPHARMAHealthcareLot size: 550

Aurobindo Pharma Limited Open Interest & PCR Analysis

₹1644.80Updated 28 Oct 2026, 03:30 pm IST
PCR
0.63Bearish signal
Max Pain
₹1600Spot above by ₹45
Total CE OI
2.54MCall writers
Total PE OI
1.60MPut writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
AI AnalysisGenerated daily after market close · AI-powered

OI Buildup Pattern

Current open‑interest shows a neutral buildup, with the spot price flat at ₹1,644.8 and total call‑option open‑interest unchanged, indicating neither a pronounced long nor short accumulation overall. Call‑option open‑interest stands at 2,542,100 contracts while put‑option open‑interest is 1,604,350 contracts, reflecting a modest net long bias in the underlying positions across the market segment today. With price unchanged and open‑interest flat, the market rests in a short‑covering stance, implying that short sellers have paused unwinding as no decisive price move occurs today.

Put-Call Ratio

The put‑call ratio stands at 0.631, indicating a modest call‑side dominance for this expiry, which aligns with the broader market’s slight optimism on earnings outlook for now. Yesterday’s ratio was 0.423, marking a day‑over‑day increase that points to a relative rise in put demand compared with calls and reflects a shift toward downside risk.

Futures OI

Futures open‑interest registers zero change, confirming that no new contracts have been added or withdrawn in the current session across both long and short sides today overall in today’s market environment. The flat futures OI, together with steady spot pricing, suggests market participants are holding existing positions rather than initiating fresh speculative bets in the current expiry cycle.

Data Summary

Overall, total call OI is 2,542,100 and put OI is 1,604,350, with a neutral buildup and unchanged futures OI for this expiry as of today’s market snapshot.

Data as of 2026-10-28

Related Analysis

Same Sector

ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutralDIVISLABDivi's Laboratories LimitedNeutral

Frequently Asked Questions

What is Aurobindo Pharma Limited PCR (Put-Call Ratio) today?
Aurobindo Pharma Limited's current PCR is 0.63. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Aurobindo Pharma Limited's PCR of 0.63 indicates bearish sentiment.
What is Aurobindo Pharma Limited OI buildup type today?
Aurobindo Pharma Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Aurobindo Pharma Limited?
Aurobindo Pharma Limited has total CE (call) OI of 2542100 contracts and total PE (put) OI of 1604350 contracts for the nearest expiry. The PCR is 0.63.
How is open interest analysis useful for Aurobindo Pharma Limited trading?
OI analysis for Aurobindo Pharma Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Aurobindo Pharma Limited?
Aurobindo Pharma Limited's max pain is ₹1,600 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.